US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exicure, Inc.

4.39

+0.36008.93%

Post-market: 4.480.0900+2.05%18:20 EST

Volume:33.61K

Turnover:144.93K

Market Cap:27.98M

PE:-3.03

High:4.45

Open:4.04

Low:4.04

Close:4.03

52wk High:15.91

52wk Low:3.10

Shares:6.37M

Float Shares:2.33M

Volume Ratio:0.72

T/O Rate:1.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4479

EPS(LYR):-4.7478

ROE:-217.87%

ROA:-44.91%

PB:4.04

PE(LYR):-0.92

Loading ...

Overview Company News Filings

Exicure kündigt erfolgreiche Phase-2-Studie mit Burixafor zur schnellen Stammzellmobilisierung bei Multiplem Myelom und Lymphom an

Exicure Reports Phase 2 Success for Burixafor in Rapid Stem Cell Mobilization for Transplant Patients

Exicure Achieves Milestone in Collaboration with GPCR Therapeutics

Exicure to present data from burixafor Phase 2 trial at 2026 Tandem Meetings

Exicure Reports Positive Phase 2 Results for Burixafor in Multiple Myeloma Stem Cell Mobilization

Exicure HiTron Inc. Reports Disposal of Exicure Inc. Common Shares

Exicure HiTron Inc. Reports Disposal of Exicure Inc. Common Shares

Crude Oil Down 1%; AutoZone Shares Dip After Q1 Results

Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial

Stocks to Watch: Alexander & Baldwin, Exicure, Mama's Creations

Exicure Surges on Positive Data for Blood Cancer Treatment

Exicure Reports Positive Phase 2 Results for Burixafor in Multiple Myeloma Stem Cell Mobilization

Exicure Inc. Announces Early Redemption of $3.1 Million Convertible Bonds to Simplify Capital Structure

Exicure Inc. Held Annual Shareholder Meeting

Biotechnology company Exicure Q3 net loss widens, existing cash not sufficient to continue to fund operations

Exicure Q3 EPS $(0.39) Up From $(0.57) YoY

Exicure reports third quarter net loss of $2.4 million

Exicure Q3 Operating Income USD -2.391 Million

THOMSON REUTERS

Exicure Inc - Cash Not Sufficient to Fund Operations

THOMSON REUTERS

Exicure, Inc. Reports Third Quarter 2025 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/XCUR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XCUR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XCUR\",,,,,undefined,":{"symbol":"XCUR","market":"US","secType":"STK","nameCN":"Exicure, Inc.","latestPrice":4.39,"timestamp":1770670800000,"preClose":4.03,"halted":0,"volume":33607,"hourTrading":{"tag":"盘后","latestPrice":4.48,"preClose":4.39,"latestTime":"18:20 EST","volume":22,"amount":98.29999520000001,"timestamp":1770679238092,"change":0.09,"changeRate":0.020501,"amplitude":0.004556},"delay":0,"changeRate":0.08933002481389564,"floatShares":2327862,"shares":6373869,"eps":-1.4479432,"marketStatus":"Post-Mkt","change":0.36,"latestTime":"02-09 19:05:40 EST","open":4.04,"high":4.45,"low":4.04,"amount":144933.1348339,"amplitude":0.101737,"askPrice":4.49,"askSize":90,"bidPrice":4.28,"bidSize":23,"shortable":0,"etf":0,"ttmEps":-1.4479432,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1770685200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":4.03,"preHourTrading":{"tag":"盘前","latestPrice":4.19,"preClose":4.03,"latestTime":"08:08 EST","volume":386,"amount":1651.8199904,"timestamp":1770642536517,"change":0.16,"changeRate":0.039702,"amplitude":0.019851},"postHourTrading":{"tag":"盘后","latestPrice":4.48,"preClose":4.39,"latestTime":"18:20 EST","volume":22,"amount":98.29999520000001,"timestamp":1770679238092,"change":0.09,"changeRate":0.020501,"amplitude":0.004556},"volumeRatio":0.71563},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XCUR\",,,,,undefined,":{"symbol":"XCUR","floatShares":2327862,"roa":"-44.91%","roe":"-217.87%","lyrEps":-4.747763,"volumeRatio":0.71563,"shares":6373869,"dividePrice":0,"high":4.45,"amplitude":0.101737,"preClose":4.03,"low":4.04,"week52Low":3.1006,"pbRate":"4.04","week52High":15.91,"institutionHeld":0,"latestPrice":4.39,"committee":-0.59292,"eps":-1.4479432,"divideRate":0,"volume":33607,"delay":0,"ttmEps":-1.4479432,"open":4.04,"prevYearClose":5.42,"prevWeekClose":4.03,"prevMonthClose":4.07,"prevQuarterClose":5.42,"fiveDayClose":4.2,"twentyDayClose":5.84,"sixtyDayClose":3.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XCUR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-07","symbol":"XCUR","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-0.39},{"market":"US","date":"2025-08-08","symbol":"XCUR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"post","actualEps":-0.41},{"market":"US","date":"2025-06-27","symbol":"XCUR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1750996800000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2025-03-18","symbol":"XCUR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"post","actualEps":-3.39},{"market":"US","date":"2024-11-14","symbol":"XCUR","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.57}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XCUR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XCUR\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/XCUR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"XCUR","date":"2026-02-06","current":-3.031887,"percent":0.37561,"low":-19.17664,"twenty":-4.880802,"median":-0.594406,"eighty":-0.130649,"high":8.65467,"avg":-2.201211,"sd":3.668615,"marketCap":27152681},"quantilePoints":[{"date":"2021-02-12","current":-10.848115,"twenty":-11.04391,"median":-8.860213,"eighty":-5.933322,"marketCap":238267993},{"date":"2021-02-19","current":-10.050459,"twenty":-11.004271,"median":-8.869724,"eighty":-5.963959,"marketCap":220748287},{"date":"2021-02-26","current":-8.654562,"twenty":-10.995346,"median":-8.880216,"eighty":-5.992331,"marketCap":190088804},{"date":"2021-03-05","current":-8.215852,"twenty":-10.987291,"median":-8.87497,"eighty":-5.996865,"marketCap":180452964},{"date":"2021-03-12","current":-8.736125,"twenty":-10.978784,"median":-8.869724,"eighty":-5.996865,"marketCap":215502728},{"date":"2021-03-19","current":-8.736125,"twenty":-10.951154,"median":-8.869724,"eighty":-5.999936,"marketCap":215502728},{"date":"2021-03-26","current":-7.809026,"twenty":-10.886878,"median":-8.860213,"eighty":-6.020628,"marketCap":192633050},{"date":"2021-04-01","current":-7.987314,"twenty":-10.878997,"median":-8.860213,"eighty":-6.054263,"marketCap":197031066},{"date":"2021-04-09","current":-7.238503,"twenty":-10.878997,"median":-8.84409,"eighty":-6.063387,"marketCap":178559402},{"date":"2021-04-16","current":-6.418377,"twenty":-10.862276,"median":-8.829133,"eighty":-6.075284,"marketCap":158328536},{"date":"2021-04-23","current":-6.420807,"twenty":-10.848115,"median":-8.80082,"eighty":-6.063387,"marketCap":158388476},{"date":"2021-04-30","current":-7.027217,"twenty":-10.791263,"median":-8.788193,"eighty":-6.064096,"marketCap":173347387},{"date":"2021-05-07","current":-6.456478,"twenty":-10.791263,"median":-8.758197,"eighty":-6.075284,"marketCap":159268411},{"date":"2021-05-14","current":-3.412208,"twenty":-10.780681,"median":-8.736125,"eighty":-6.063387,"marketCap":130670491},{"date":"2021-05-21","current":-3.722408,"twenty":-10.780605,"median":-8.712543,"eighty":-5.996865,"marketCap":142549626},{"date":"2021-05-28","current":-3.837298,"twenty":-10.766687,"median":-8.697988,"eighty":-5.95715,"marketCap":146949308},{"date":"2021-06-04","current":-3.837298,"twenty":-10.745153,"median":-8.69617,"eighty":-5.902906,"marketCap":146949308},{"date":"2021-06-11","current":-3.860275,"twenty":-10.738939,"median":-8.675625,"eighty":-5.886089,"marketCap":147829243},{"date":"2021-06-18","current":-3.81432,"twenty":-10.738731,"median":-8.654562,"eighty":-5.875095,"marketCap":146069370},{"date":"2021-06-25","current":-3.584541,"twenty":-10.710569,"median":-8.578855,"eighty":-5.798664,"marketCap":137270010},{"date":"2021-07-02","current":-3.515608,"twenty":-10.691573,"median":-8.558135,"eighty":-5.758673,"marketCap":134630202},{"date":"2021-07-09","current":-3.584541,"twenty":-10.685216,"median":-8.527955,"eighty":-5.751535,"marketCap":137270010},{"date":"2021-07-16","current":-3.216896,"twenty":-10.668985,"median":-8.512124,"eighty":-5.718791,"marketCap":123191037},{"date":"2021-07-23","current":-3.28583,"twenty":-10.653085,"median":-8.482115,"eighty":-5.695803,"marketCap":125830842},{"date":"2021-07-30","current":-3.102007,"twenty":-10.638834,"median":-8.417202,"eighty":-5.65255,"marketCap":118791355},{"date":"2021-08-06","current":-3.010096,"twenty":-10.602487,"median":-8.408698,"eighty":-5.611111,"marketCap":115271612},{"date":"2021-08-13","current":-2.172904,"twenty":-10.582641,"median":-8.377834,"eighty":-5.59871,"marketCap":104849146},{"date":"2021-08-20","current":-2.099865,"twenty":-10.578913,"median":-8.366655,"eighty":-5.59871,"marketCap":101324805},{"date":"2021-08-27","current":-2.501579,"twenty":-10.576427,"median":-8.282317,"eighty":-5.59871,"marketCap":120708683},{"date":"2021-09-03","current":-2.556358,"twenty":-10.576427,"median":-8.215852,"eighty":-5.558719,"marketCap":123351939},{"date":"2021-09-10","current":-2.483319,"twenty":-10.574628,"median":-8.190044,"eighty":-5.539847,"marketCap":119827595},{"date":"2021-09-17","current":-2.574618,"twenty":-10.557394,"median":-8.155102,"eighty":-5.507564,"marketCap":124233023},{"date":"2021-09-24","current":-2.355501,"twenty":-10.532579,"median":-8.096203,"eighty":-5.442576,"marketCap":113659999},{"date":"2021-10-01","current":-2.118125,"twenty":-10.528062,"median":-8.073148,"eighty":-5.380537,"marketCap":102205890},{"date":"2021-10-08","current":-2.337241,"twenty":-10.525438,"median":-8.051328,"eighty":-5.295997,"marketCap":112778914},{"date":"2021-10-15","current":-2.154644,"twenty":-10.510804,"median":-8.003782,"eighty":-5.250314,"marketCap":103968061},{"date":"2021-10-22","current":-2.099865,"twenty":-10.494756,"median":-7.987314,"eighty":-5.201314,"marketCap":101324805},{"date":"2021-10-29","current":-2.063346,"twenty":-10.493101,"median":-7.975373,"eighty":-5.106823,"marketCap":99562634},{"date":"2021-11-05","current":-2.026827,"twenty":-10.490618,"median":-7.959986,"eighty":-4.998848,"marketCap":97800465},{"date":"2021-11-12","current":-2.008567,"twenty":-10.488049,"median":-7.912549,"eighty":-4.930438,"marketCap":96919380},{"date":"2021-11-19","current":-0.643811,"twenty":-10.478588,"median":-7.896789,"eighty":-4.898699,"marketCap":40535633},{"date":"2021-11-26","current":-0.693636,"twenty":-10.466,"median":-7.883154,"eighty":-4.801341,"marketCap":43672739},{"date":"2021-12-03","current":-0.594406,"twenty":-10.448351,"median":-7.838498,"eighty":-4.687409,"marketCap":37424964},{"date":"2021-12-10","current":-0.637233,"twenty":-10.44375,"median":-7.778046,"eighty":-4.650929,"marketCap":40121465},{"date":"2021-12-17","current":-0.403469,"twenty":-10.440328,"median":-7.776993,"eighty":-4.641331,"marketCap":25403239},{"date":"2021-12-23","current":-0.349342,"twenty":-10.440328,"median":-7.774654,"eighty":-4.551973,"marketCap":21995240},{"date":"2021-12-31","current":-0.324607,"twenty":-10.440328,"median":-7.773368,"eighty":-4.506123,"marketCap":20437877},{"date":"2022-01-07","current":-0.344688,"twenty":-10.420123,"median":-7.743987,"eighty":-4.398986,"marketCap":21702232},{"date":"2022-01-14","current":-0.305813,"twenty":-10.420123,"median":-7.697375,"eighty":-4.158987,"marketCap":19254614},{"date":"2022-01-21","current":-0.272813,"twenty":-10.401193,"median":-7.683917,"eighty":-3.998142,"marketCap":17176854},{"date":"2022-01-28","current":-0.269876,"twenty":-10.392703,"median":-7.662426,"eighty":-3.952187,"marketCap":16991923},{"date":"2022-02-04","current":-0.362657,"twenty":-10.377419,"median":-7.630738,"eighty":-3.924613,"marketCap":22833579},{"date":"2022-02-11","current":-0.300976,"twenty":-10.373833,"median":-7.58885,"eighty":-3.85568,"marketCap":18950021},{"date":"2022-02-18","current":-0.305986,"twenty":-10.372566,"median":-7.567828,"eighty":-3.832702,"marketCap":19265492},{"date":"2022-02-25","current":-0.313588,"twenty":-10.372249,"median":-7.567828,"eighty":-3.805129,"marketCap":19744138},{"date":"2022-03-04","current":-0.351426,"twenty":-10.357706,"median":-7.54109,"eighty":-3.699431,"marketCap":22126490},{"date":"2022-03-11","current":-0.341059,"twenty":-10.338052,"median":-7.488107,"eighty":-3.648879,"marketCap":21473788},{"date":"2022-03-18","current":-0.466495,"twenty":-10.317801,"median":-7.453716,"eighty":-3.56247,"marketCap":29371447},{"date":"2022-03-25","current":-0.498052,"twenty":-10.308727,"median":-7.407849,"eighty":-3.515608,"marketCap":31926138},{"date":"2022-04-01","current":-0.351701,"twenty":-10.308727,"median":-7.378472,"eighty":-3.49263,"marketCap":22544765},{"date":"2022-04-08","current":-0.406679,"twenty":-10.30349,"median":-7.361837,"eighty":-3.446348,"marketCap":26068921},{"date":"2022-04-14","current":-0.335036,"twenty":-10.299998,"median":-7.315567,"eighty":-3.412726,"marketCap":21476468},{"date":"2022-04-22","current":-0.33063,"twenty":-10.284223,"median":-7.289317,"eighty":-3.363954,"marketCap":21194045},{"date":"2022-04-29","current":-0.268182,"twenty":-10.256233,"median":-7.269814,"eighty":-3.304212,"marketCap":17190998},{"date":"2022-05-06","current":-0.237341,"twenty":-10.246454,"median":-7.255584,"eighty":-3.262852,"marketCap":15214031},{"date":"2022-05-13","current":-0.235042,"twenty":-10.241521,"median":-7.223051,"eighty":-3.193918,"marketCap":15066680},{"date":"2022-05-20","current":-0.296916,"twenty":-10.24085,"median":-7.17991,"eighty":-3.111198,"marketCap":17806915},{"date":"2022-05-27","current":-0.25719,"twenty":-10.232304,"median":-7.156784,"eighty":-2.807891,"marketCap":15424471},{"date":"2022-06-03","current":-0.254938,"twenty":-10.220993,"median":-7.123651,"eighty":-2.56001,"marketCap":15289384},{"date":"2022-06-10","current":-0.270295,"twenty":-10.218792,"median":-7.074537,"eighty":-2.527142,"marketCap":16210430},{"date":"2022-06-17","current":-0.247976,"twenty":-10.209773,"median":-7.035276,"eighty":-2.486971,"marketCap":14871843},{"date":"2022-06-24","current":-0.2748,"twenty":-10.208906,"median":-7.027217,"eighty":-2.465059,"marketCap":16480608},{"date":"2022-07-01","current":-0.141291,"twenty":-10.208906,"median":-6.99042,"eighty":-2.4468,"marketCap":8473627},{"date":"2022-07-08","current":-0.135148,"twenty":-10.208906,"median":-6.942455,"eighty":-2.384717,"marketCap":8105209},{"date":"2022-07-15","current":-0.139005,"twenty":-10.183482,"median":-6.920203,"eighty":-2.333589,"marketCap":8336548},{"date":"2022-07-22","current":-0.164655,"twenty":-10.169881,"median":-6.891825,"eighty":-2.227683,"marketCap":9874839},{"date":"2022-07-29","current":-0.134041,"twenty":-10.149254,"median":-6.874111,"eighty":-2.205772,"marketCap":8038814},{"date":"2022-08-05","current":-0.187822,"twenty":-10.14455,"median":-6.831467,"eighty":-2.187512,"marketCap":11264264},{"date":"2022-08-12","current":-0.18865,"twenty":-10.136005,"median":-6.792318,"eighty":-2.154644,"marketCap":11313886},{"date":"2022-08-19","current":-0.179188,"twenty":-10.133381,"median":-6.776236,"eighty":-2.136385,"marketCap":9528159},{"date":"2022-08-26","current":-0.167989,"twenty":-10.133259,"median":-6.706177,"eighty":-2.114473,"marketCap":8932649},{"date":"2022-09-02","current":-0.157723,"twenty":-10.133259,"median":-6.596341,"eighty":-2.099865,"marketCap":8386765},{"date":"2022-09-09","current":-0.165189,"twenty":-10.129645,"median":-6.560697,"eighty":-2.081606,"marketCap":8783771},{"date":"2022-09-16","current":-0.172655,"twenty":-10.12014,"median":-6.473437,"eighty":-2.056042,"marketCap":9180778},{"date":"2022-09-23","current":-0.143724,"twenty":-10.11541,"median":-6.458732,"eighty":-2.008567,"marketCap":7642377},{"date":"2022-09-30","current":-0.146524,"twenty":-10.107933,"median":-6.432654,"eighty":-1.739784,"marketCap":7791255},{"date":"2022-10-07","current":-0.158656,"twenty":-10.088275,"median":-6.419592,"eighty":-0.736212,"marketCap":8436391},{"date":"2022-10-14","current":-0.144657,"twenty":-10.078492,"median":-6.369589,"eighty":-0.655259,"marketCap":7692003},{"date":"2022-10-21","current":-0.130649,"twenty":-10.073049,"median":-6.338959,"eighty":-0.640788,"marketCap":6947119},{"date":"2022-10-28","current":-0.131591,"twenty":-10.058044,"median":-6.327545,"eighty":-0.603139,"marketCap":6997242},{"date":"2022-11-04","current":-0.121325,"twenty":-10.047522,"median":-6.306524,"eighty":-0.522681,"marketCap":6451357},{"date":"2022-11-11","current":-0.114833,"twenty":-10.029811,"median":-6.306524,"eighty":-0.464353,"marketCap":6106104},{"date":"2022-11-18","current":-0.162135,"twenty":-10.019309,"median":-6.269673,"eighty":-0.420504,"marketCap":5642798},{"date":"2022-11-25","current":-0.161194,"twenty":-10.018049,"median":-6.243458,"eighty":-0.404753,"marketCap":5610031},{"date":"2022-12-02","current":-0.140824,"twenty":-10.011558,"median":-6.242452,"eighty":-0.396065,"marketCap":4901082},{"date":"2022-12-09","current":-0.119826,"twenty":-10.004506,"median":-6.201415,"eighty":-0.386838,"marketCap":4170289},{"date":"2022-12-16","current":-0.101281,"twenty":-10.003231,"median":-6.19592,"eighty":-0.377863,"marketCap":3524887},{"date":"2022-12-23","current":-0.182591,"twenty":-10.001658,"median":-6.182446,"eighty":-0.36352,"marketCap":6354726},{"date":"2022-12-30","current":-0.164047,"twenty":-9.995465,"median":-6.169882,"eighty":-0.36177,"marketCap":5709324},{"date":"2023-01-06","current":-0.218254,"twenty":-9.970694,"median":-6.14886,"eighty":-0.357819,"marketCap":7595883},{"date":"2023-01-13","current":-0.186871,"twenty":-9.96774,"median":-6.13835,"eighty":-0.354236,"marketCap":6503665},{"date":"2023-01-20","current":-0.211121,"twenty":-9.96774,"median":-6.117328,"eighty":-0.350698,"marketCap":7347652},{"date":"2023-01-27","current":-0.199709,"twenty":-9.96774,"median":-6.096306,"eighty":-0.348895,"marketCap":6950482},{"date":"2023-02-03","current":-0.203989,"twenty":-9.959782,"median":-6.096306,"eighty":-0.344446,"marketCap":7099420},{"date":"2023-02-10","current":-0.192563,"twenty":-9.957792,"median":-6.096306,"eighty":-0.336843,"marketCap":6701754},{"date":"2023-02-17","current":-0.168868,"twenty":-9.957629,"median":-6.075284,"eighty":-0.330129,"marketCap":5877128},{"date":"2023-02-24","current":-0.27399,"twenty":-9.949534,"median":-6.064096,"eighty":-0.327118,"marketCap":9535678},{"date":"2023-03-03","current":-0.278797,"twenty":-9.936159,"median":-6.058032,"eighty":-0.318616,"marketCap":9702970},{"date":"2023-03-10","current":-0.257142,"twenty":-9.926163,"median":-5.996865,"eighty":-0.312272,"marketCap":8949317},{"date":"2023-03-17","current":-0.242746,"twenty":-9.923057,"median":-5.994031,"eighty":-0.307069,"marketCap":8448276},{"date":"2023-03-24","current":-0.228325,"twenty":-9.920692,"median":-5.954828,"eighty":-0.303878,"marketCap":7946398},{"date":"2023-03-31","current":-2.822389,"twenty":-9.904086,"median":-5.8966,"eighty":-0.305917,"marketCap":7287408},{"date":"2023-04-06","current":-3.305209,"twenty":-9.894067,"median":-5.886089,"eighty":-0.306055,"marketCap":8534049},{"date":"2023-04-14","current":-3.597169,"twenty":-9.894002,"median":-5.886089,"eighty":-0.306505,"marketCap":9287890},{"date":"2023-04-21","current":-3.240401,"twenty":-9.893331,"median":-5.878633,"eighty":-0.307053,"marketCap":8366715},{"date":"2023-04-28","current":-2.916361,"twenty":-9.887196,"median":-5.838007,"eighty":-0.307552,"marketCap":7530043},{"date":"2023-05-05","current":-3.402421,"twenty":-9.875595,"median":-5.798664,"eighty":-0.309476,"marketCap":8785050},{"date":"2023-05-12","current":-3.272805,"twenty":-9.859623,"median":-5.758673,"eighty":-0.311618,"marketCap":8450382},{"date":"2023-05-19","current":-3.175593,"twenty":-9.842937,"median":-5.758626,"eighty":-0.312193,"marketCap":8199380},{"date":"2023-05-26","current":-2.75434,"twenty":-9.820069,"median":-5.719653,"eighty":-0.312272,"marketCap":7111707},{"date":"2023-06-02","current":-2.841507,"twenty":-9.778989,"median":-5.698687,"eighty":-0.312272,"marketCap":7336772},{"date":"2023-06-09","current":-3.045977,"twenty":-9.73735,"median":-5.661783,"eighty":-0.312272,"marketCap":7864712},{"date":"2023-06-16","current":-3.726461,"twenty":-9.708781,"median":-5.599721,"eighty":-0.312272,"marketCap":9621722},{"date":"2023-06-23","current":-3.953289,"twenty":-9.628704,"median":-5.59871,"eighty":-0.312193,"marketCap":10207392},{"date":"2023-06-30","current":-4.679787,"twenty":-9.571866,"median":-5.59871,"eighty":-0.312113,"marketCap":12083209},{"date":"2023-07-07","current":-3.726461,"twenty":-9.517345,"median":-5.59871,"eighty":-0.312113,"marketCap":9621722},{"date":"2023-07-14","current":-4.082905,"twenty":-9.428678,"median":-5.541532,"eighty":-0.312113,"marketCap":10542060},{"date":"2023-07-21","current":7.191013,"twenty":-9.389383,"median":-5.500121,"eighty":-0.306332,"marketCap":9772586},{"date":"2023-07-28","current":6.809189,"twenty":-9.338627,"median":-5.439746,"eighty":-0.297796,"marketCap":9253688},{"date":"2023-08-04","current":6.03345,"twenty":-9.303224,"median":-5.323829,"eighty":-0.288977,"marketCap":8199459},{"date":"2023-08-11","current":5.466442,"twenty":-9.248308,"median":-5.258788,"eighty":-0.283332,"marketCap":7428895},{"date":"2023-08-18","current":2.314022,"twenty":-9.212921,"median":-5.198802,"eighty":-0.280575,"marketCap":7092476},{"date":"2023-08-25","current":2.354371,"twenty":-9.171234,"median":-5.078829,"eighty":-0.275321,"marketCap":7216147},{"date":"2023-09-01","current":2.567686,"twenty":-9.133155,"median":-4.958857,"eighty":-0.273048,"marketCap":7869959},{"date":"2023-09-08","current":2.342238,"twenty":-9.116111,"median":-4.908214,"eighty":-0.271009,"marketCap":7178959},{"date":"2023-09-15","current":2.418986,"twenty":-9.056313,"median":-4.799362,"eighty":-0.268022,"marketCap":7414193},{"date":"2023-09-22","current":2.116225,"twenty":-9.01825,"median":-4.67179,"eighty":-0.259156,"marketCap":6486230},{"date":"2023-09-29","current":2.031576,"twenty":-8.977038,"median":-4.650929,"eighty":-0.257477,"marketCap":6226781},{"date":"2023-10-06","current":1.946927,"twenty":-8.926227,"median":-4.628933,"eighty":-0.254798,"marketCap":5967331},{"date":"2023-10-13","current":2.114811,"twenty":-8.90578,"median":-4.506123,"eighty":-0.248795,"marketCap":6481897},{"date":"2023-10-20","current":1.936205,"twenty":-8.869724,"median":-4.386288,"eighty":-0.244904,"marketCap":5934468},{"date":"2023-10-27","current":1.644448,"twenty":-8.860213,"median":-4.158987,"eighty":-0.241628,"marketCap":5040233},{"date":"2023-11-03","current":1.807256,"twenty":-8.822859,"median":-4.018097,"eighty":-0.236099,"marketCap":5539240},{"date":"2023-11-10","current":1.69298,"twenty":-8.803345,"median":-3.98148,"eighty":-0.230993,"marketCap":5188984},{"date":"2023-11-17","current":1.594223,"twenty":-8.803345,"median":-3.952187,"eighty":-0.218303,"marketCap":4886293},{"date":"2023-11-24","current":1.411099,"twenty":-8.803345,"median":-3.929209,"eighty":-0.211692,"marketCap":4325018},{"date":"2023-12-01","current":1.300773,"twenty":-8.788193,"median":-3.837298,"eighty":-0.207419,"marketCap":3986869},{"date":"2023-12-08","current":1.13514,"twenty":-8.788193,"median":-3.81432,"eighty":-0.203844,"marketCap":3479205},{"date":"2023-12-15","current":1.636547,"twenty":-8.788193,"median":-3.777588,"eighty":-0.201136,"marketCap":5016018},{"date":"2023-12-22","current":1.630904,"twenty":-8.788193,"median":-3.724435,"eighty":-0.198585,"marketCap":4998721},{"date":"2023-12-29","current":1.665046,"twenty":-8.788193,"median":-3.699147,"eighty":-0.196,"marketCap":5103365},{"date":"2024-01-05","current":1.681129,"twenty":-8.788193,"median":-3.669053,"eighty":-0.19335,"marketCap":5152661},{"date":"2024-01-12","current":2.144441,"twenty":-8.788193,"median":-3.595711,"eighty":-0.190473,"marketCap":6572713},{"date":"2024-01-19","current":1.70991,"twenty":-8.788193,"median":-3.564441,"eighty":-0.189207,"marketCap":5240874},{"date":"2024-01-26","current":1.503931,"twenty":-8.788193,"median":-3.535311,"eighty":-0.186697,"marketCap":4609547},{"date":"2024-02-02","current":1.523259,"twenty":-8.788193,"median":-3.505879,"eighty":-0.182109,"marketCap":4668788},{"date":"2024-02-09","current":1.664764,"twenty":-8.788193,"median":-3.496132,"eighty":-0.179188,"marketCap":5102501},{"date":"2024-02-16","current":1.721196,"twenty":-8.788193,"median":-3.458163,"eighty":-0.172842,"marketCap":5275467},{"date":"2024-02-23","current":1.672382,"twenty":-8.788193,"median":-3.434825,"eighty":-0.170867,"marketCap":5125851},{"date":"2024-03-01","current":2.003642,"twenty":-8.788193,"median":-3.412726,"eighty":-0.167989,"marketCap":6141162},{"date":"2024-03-08","current":1.834062,"twenty":-8.788193,"median":-3.354763,"eighty":-0.166546,"marketCap":5621399},{"date":"2024-03-15","current":1.724018,"twenty":-8.788193,"median":-3.331785,"eighty":-0.165189,"marketCap":5284115},{"date":"2024-03-22","current":1.757878,"twenty":-8.788193,"median":-3.28583,"eighty":-0.163613,"marketCap":5387895},{"date":"2024-03-28","current":1.742641,"twenty":-8.788193,"median":-3.262852,"eighty":-0.161194,"marketCap":5341194},{"date":"2024-04-05","current":1.580115,"twenty":-8.788193,"median":-3.201119,"eighty":-0.15869,"marketCap":4843051},{"date":"2024-04-12","current":1.658556,"twenty":-8.788193,"median":-3.171646,"eighty":-0.157723,"marketCap":5083474},{"date":"2024-04-19","current":1.633162,"twenty":-8.788193,"median":-3.124985,"eighty":-0.149697,"marketCap":5005640},{"date":"2024-04-26","current":1.436211,"twenty":-8.788193,"median":-3.045977,"eighty":-0.146888,"marketCap":4401988},{"date":"2024-05-03","current":1.413638,"twenty":-8.788193,"median":-2.965939,"eighty":-0.144308,"marketCap":4332801},{"date":"2024-05-10","current":1.30825,"twenty":-8.788193,"median":-2.916361,"eighty":-0.142706,"marketCap":4009787},{"date":"2024-05-17","current":1.464428,"twenty":-8.788193,"median":-2.841507,"eighty":-0.140259,"marketCap":4488471},{"date":"2024-05-24","current":1.304965,"twenty":-8.788193,"median":-2.773783,"eighty":-0.137561,"marketCap":3874441},{"date":"2024-05-31","current":1.022417,"twenty":-8.788193,"median":-2.711384,"eighty":-0.135694,"marketCap":3035555},{"date":"2024-06-07","current":1.379243,"twenty":-8.788193,"median":-2.556358,"eighty":-0.131965,"marketCap":4094973},{"date":"2024-06-14","current":-0.171448,"twenty":-8.788193,"median":-2.510708,"eighty":-0.131778,"marketCap":2899864},{"date":"2024-06-21","current":-0.21177,"twenty":-8.788193,"median":-2.483319,"eighty":-0.131591,"marketCap":2824167},{"date":"2024-06-28","current":-0.196169,"twenty":-8.803345,"median":-2.455929,"eighty":-0.131591,"marketCap":2616107},{"date":"2024-07-05","current":-0.204472,"twenty":-8.803345,"median":-2.42854,"eighty":-0.131591,"marketCap":2726841},{"date":"2024-07-12","current":-0.212841,"twenty":-8.803345,"median":-2.337241,"eighty":-0.131591,"marketCap":2838441},{"date":"2024-07-15","current":-0.214268,"twenty":-8.803345,"median":-2.328112,"eighty":-0.131591,"marketCap":2857474},{"date":"2024-08-02","current":-0.321045,"twenty":-8.838158,"median":-2.209424,"eighty":-0.130656,"marketCap":4281453},{"date":"2024-08-09","current":-0.352961,"twenty":-8.793244,"median":-2.172904,"eighty":-0.130656,"marketCap":4707089},{"date":"2024-08-16","current":-0.383333,"twenty":-8.748588,"median":-2.154644,"eighty":-0.130656,"marketCap":3132600},{"date":"2024-08-23","current":-0.414457,"twenty":-8.712543,"median":-2.118125,"eighty":-0.130656,"marketCap":3386946},{"date":"2024-08-30","current":-0.395931,"twenty":-8.696534,"median":-2.099865,"eighty":-0.130656,"marketCap":3235548},{"date":"2024-09-06","current":-0.395931,"twenty":-8.69617,"median":-2.081606,"eighty":-0.130656,"marketCap":3235548},{"date":"2024-09-13","current":-0.323944,"twenty":-8.675625,"median":-2.026827,"eighty":-0.130656,"marketCap":2647267},{"date":"2024-09-20","current":-0.83209,"twenty":-8.561467,"median":-1.953788,"eighty":-0.130656,"marketCap":6799843},{"date":"2024-09-27","current":-0.806683,"twenty":-8.484698,"median":-0.895609,"eighty":-0.130656,"marketCap":6592214},{"date":"2024-10-04","current":-0.586486,"twenty":-8.359171,"median":-0.774924,"eighty":-0.130656,"marketCap":4792764},{"date":"2024-10-11","current":-0.576492,"twenty":-8.193627,"median":-0.665085,"eighty":-0.130656,"marketCap":4711090},{"date":"2024-10-18","current":-0.652759,"twenty":-8.096203,"median":-0.652759,"eighty":-0.130656,"marketCap":5334347},{"date":"2024-10-25","current":-0.522656,"twenty":-8.004225,"median":-0.640452,"eighty":-0.130656,"marketCap":4271143},{"date":"2024-10-31","current":-0.587707,"twenty":-7.976555,"median":-0.608961,"eighty":-0.130656,"marketCap":4802745},{"date":"2024-11-08","current":-0.578735,"twenty":-7.890145,"median":-0.601166,"eighty":-0.130654,"marketCap":4729421},{"date":"2024-11-15","current":-0.713324,"twenty":-7.774397,"median":-0.601166,"eighty":-0.130654,"marketCap":5829286},{"date":"2024-11-22","current":-4.968196,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":19907563},{"date":"2024-11-29","current":-19.17664,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":76840795},{"date":"2024-12-06","current":-14.924092,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":59800837},{"date":"2024-12-13","current":-11.380027,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":45599767},{"date":"2024-12-20","current":-10.235521,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":41013733},{"date":"2024-12-27","current":-11.217455,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":44948342},{"date":"2025-01-03","current":-9.87136,"twenty":-7.713328,"median":-0.601166,"eighty":-0.130654,"marketCap":39554541},{"date":"2025-01-10","current":-6.818294,"twenty":-7.683917,"median":-0.601166,"eighty":-0.130653,"marketCap":27320906},{"date":"2025-01-17","current":-6.742451,"twenty":-7.522773,"median":-0.601166,"eighty":-0.130653,"marketCap":27017003},{"date":"2025-01-24","current":-10.360167,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":41513190},{"date":"2025-01-31","current":-8.198639,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":32851946},{"date":"2025-02-07","current":-8.721956,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":34948879},{"date":"2025-02-14","current":-7.652569,"twenty":-7.474858,"median":-0.601166,"eighty":-0.130653,"marketCap":30663842},{"date":"2025-02-21","current":-6.401157,"twenty":-7.397163,"median":-0.601166,"eighty":-0.130653,"marketCap":25649438},{"date":"2025-02-28","current":-5.77166,"twenty":-7.335924,"median":-0.601166,"eighty":-0.130653,"marketCap":23127041},{"date":"2025-03-07","current":-8.661282,"twenty":-7.361837,"median":-0.597786,"eighty":-0.130651,"marketCap":34705756},{"date":"2025-03-14","current":-10.026458,"twenty":-7.454477,"median":-0.597786,"eighty":-0.130651,"marketCap":40176016},{"date":"2025-03-21","current":-4.247942,"twenty":-7.546287,"median":-0.597786,"eighty":-0.130651,"marketCap":41209287},{"date":"2025-03-28","current":-9.117492,"twenty":-7.626003,"median":-0.597786,"eighty":-0.130651,"marketCap":88448794},{"date":"2025-04-04","current":-8.61603,"twenty":-7.697375,"median":-0.597786,"eighty":-0.130651,"marketCap":83584110},{"date":"2025-04-11","current":-7.359119,"twenty":-7.741051,"median":-0.601166,"eighty":-0.130653,"marketCap":71390812},{"date":"2025-04-17","current":-7.521931,"twenty":-7.741051,"median":-0.601166,"eighty":-0.130653,"marketCap":72970255},{"date":"2025-04-25","current":-7.251663,"twenty":-7.742316,"median":-0.597786,"eighty":-0.130651,"marketCap":70348380},{"date":"2025-05-02","current":-6.492957,"twenty":-7.742316,"median":-0.597786,"eighty":-0.130651,"marketCap":62988176},{"date":"2025-05-09","current":-7.411219,"twenty":-7.694683,"median":-0.597786,"eighty":-0.130651,"marketCap":71896233},{"date":"2025-05-16","current":-6.707869,"twenty":-7.637472,"median":-0.597786,"eighty":-0.130651,"marketCap":65073041},{"date":"2025-05-23","current":-6.843199,"twenty":-7.5854,"median":-0.597786,"eighty":-0.130651,"marketCap":66385874},{"date":"2025-05-30","current":-6.330145,"twenty":-7.537561,"median":-0.597786,"eighty":-0.130651,"marketCap":61408734},{"date":"2025-06-06","current":-6.44737,"twenty":-7.445084,"median":-0.597786,"eighty":-0.130651,"marketCap":62545932},{"date":"2025-06-13","current":-5.854733,"twenty":-7.394782,"median":-0.597786,"eighty":-0.130651,"marketCap":56796761},{"date":"2025-06-20","current":-4.962521,"twenty":-7.361837,"median":-0.594406,"eighty":-0.130649,"marketCap":48141415},{"date":"2025-06-27","current":-3.611178,"twenty":-7.269814,"median":-0.594406,"eighty":-0.130649,"marketCap":35032040},{"date":"2025-07-03","current":-7.307171,"twenty":-7.258665,"median":-0.594406,"eighty":-0.130649,"marketCap":42834636},{"date":"2025-07-11","current":-7.846048,"twenty":-7.251663,"median":-0.594406,"eighty":-0.130649,"marketCap":45993533},{"date":"2025-07-18","current":-8.309482,"twenty":-7.238503,"median":-0.594406,"eighty":-0.130649,"marketCap":48710184},{"date":"2025-07-25","current":-8.794471,"twenty":-7.238503,"median":-0.594406,"eighty":-0.130649,"marketCap":51553190},{"date":"2025-08-01","current":-7.684385,"twenty":-7.169902,"median":-0.594406,"eighty":-0.130649,"marketCap":45045864},{"date":"2025-08-08","current":-7.932268,"twenty":-7.169902,"median":-0.594406,"eighty":-0.130649,"marketCap":46498956},{"date":"2025-08-15","current":-5.4899,"twenty":-7.13178,"median":-0.594406,"eighty":-0.130649,"marketCap":43276882},{"date":"2025-08-22","current":-4.968961,"twenty":-7.059251,"median":-0.594406,"eighty":-0.130649,"marketCap":39170316},{"date":"2025-08-29","current":-4.496108,"twenty":-7.027217,"median":-0.594406,"eighty":-0.130649,"marketCap":35442818},{"date":"2025-09-05","current":-4.007226,"twenty":-6.985701,"median":-0.591504,"eighty":-0.1305,"marketCap":31588965},{"date":"2025-09-12","current":-2.885203,"twenty":-6.932059,"median":-0.594406,"eighty":-0.130649,"marketCap":22744054},{"date":"2025-09-19","current":-3.109608,"twenty":-6.881927,"median":-0.594406,"eighty":-0.130649,"marketCap":24513036},{"date":"2025-09-26","current":-3.141665,"twenty":-6.818294,"median":-0.594406,"eighty":-0.130649,"marketCap":24765748},{"date":"2025-10-03","current":-3.350053,"twenty":-6.774954,"median":-0.594406,"eighty":-0.130649,"marketCap":26408470},{"date":"2025-10-10","current":-4.552226,"twenty":-6.662282,"median":-0.594406,"eighty":-0.130649,"marketCap":35885194},{"date":"2025-10-17","current":-3.927096,"twenty":-6.561008,"median":-0.594406,"eighty":-0.130649,"marketCap":30957298},{"date":"2025-10-24","current":-3.798864,"twenty":-6.512495,"median":-0.594406,"eighty":-0.130649,"marketCap":29946447},{"date":"2025-10-31","current":-3.55843,"twenty":-6.484585,"median":-0.594406,"eighty":-0.130649,"marketCap":28051103},{"date":"2025-11-07","current":-3.406155,"twenty":-6.427832,"median":-0.594406,"eighty":-0.130649,"marketCap":26850718},{"date":"2025-11-14","current":-2.521508,"twenty":-6.354294,"median":-0.594406,"eighty":-0.130649,"marketCap":23270995},{"date":"2025-11-21","current":-2.886854,"twenty":-6.349465,"median":-0.594406,"eighty":-0.130649,"marketCap":26642772},{"date":"2025-11-28","current":-2.886854,"twenty":-6.347948,"median":-0.594406,"eighty":-0.130649,"marketCap":26642772},{"date":"2025-12-05","current":-4.654879,"twenty":-6.347948,"median":-0.594406,"eighty":-0.130649,"marketCap":42959877},{"date":"2025-12-12","current":-4.192153,"twenty":-6.31712,"median":-0.594406,"eighty":-0.130649,"marketCap":38689384},{"date":"2025-12-19","current":-4.205966,"twenty":-6.26502,"median":-0.594406,"eighty":-0.130649,"marketCap":38816862},{"date":"2025-12-26","current":-4.143809,"twenty":-6.133116,"median":-0.594406,"eighty":-0.130649,"marketCap":38243214},{"date":"2026-01-02","current":-3.743241,"twenty":-6.061801,"median":-0.594406,"eighty":-0.130649,"marketCap":34546369},{"date":"2026-01-09","current":-4.060933,"twenty":-5.85055,"median":-0.594406,"eighty":-0.130649,"marketCap":37478349},{"date":"2026-01-16","current":-4.316468,"twenty":-5.730334,"median":-0.594406,"eighty":-0.130649,"marketCap":39836681},{"date":"2026-01-23","current":-4.440782,"twenty":-5.418395,"median":-0.594406,"eighty":-0.130649,"marketCap":40983977},{"date":"2026-01-30","current":-2.942104,"twenty":-5.034728,"median":-0.594406,"eighty":-0.130649,"marketCap":27152681},{"date":"2026-02-06","current":-2.942104,"twenty":-4.880802,"median":-0.594406,"eighty":-0.130649,"marketCap":27152681}],"updateTime":1770681940477},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XCUR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609374199","title":"Exicure kündigt erfolgreiche Phase-2-Studie mit Burixafor zur schnellen Stammzellmobilisierung bei Multiplem Myelom und Lymphom an","url":"https://stock-news.laohu8.com/highlight/detail?id=2609374199","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609374199?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:00","pubTimestamp":1770292826,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via GlobeNewswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL7XbNjq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4588","BK4139","LU2095319765.USD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014005.SGD","SG9999014013.SGD","NDAQ","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","SG9999014039.USD","LU2210149790.SGD","LU0314104364.USD","BK4585"],"gpt_icon":0},{"id":"2609374110","title":"Exicure Reports Phase 2 Success for Burixafor in Rapid Stem Cell Mobilization for Transplant Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2609374110","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609374110?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:00","pubTimestamp":1770292826,"startTime":"0","endTime":"0","summary":"Exicure Inc. has announced the publication of results from a Phase 2 clinical study evaluating burixafor, a highly selective CXCR4 inhibitor, in the journal Annals of Hematology. The study assessed burixafor in combination with granulocyte colony-stimulating factor  in patients with multiple myeloma, non-Hodgkin's lymphoma, and Hodgkin disease undergoing autologous stem cell transplantation. The results showed that 92% of participants met the primary endpoint of collecting at least 5.0 × 10 CD34+ cells/kg within two leukapheresis sessions, with half achieving the target in a single session. Burixafor demonstrated rapid stem cell mobilization, with peak CD34+ cell counts occurring within one hour of administration, and was generally well tolerated. Additionally, Exicure recently completed another Phase 2 study evaluating burixafor in combination with G-CSF and propranolol in multiple myeloma patients. Positive topline data from this study were presented at the American Society of Hemato","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL8W2r61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014021.USD","SG9999014039.USD","LU2095319765.USD","BK4139","BK4112","LU0314104364.USD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4585","IE00B64PRP62.GBP","LU2210149790.SGD","LU2210150020.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","XCUR"],"gpt_icon":0},{"id":"2605417795","title":"Exicure Achieves Milestone in Collaboration with GPCR Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2605417795","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605417795?lang=en_us&edition=fundamental","pubTime":"2026-01-23 05:29","pubTimestamp":1769117392,"startTime":"0","endTime":"0","summary":"Exicure Inc. has achieved the first milestone under its License and Collaboration Agreement with GPCR Therapeutics Inc., following the completion of a Phase 2 clinical trial for its novel stem cell mobilizer. As part of the agreement, Exicure will make a $1 million milestone payment to GPCR Therapeutics Inc. This collaboration focuses on the development of Burixafor , a small molecule CXCR4 inhibitor, and the milestone completion also activates a future sublicensing income-sharing arrangement between the two companies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nNDL2B9pdd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2605101748","title":"Exicure to present data from burixafor Phase 2 trial at 2026 Tandem Meetings","url":"https://stock-news.laohu8.com/highlight/detail?id=2605101748","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605101748?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:15","pubTimestamp":1768997740,"startTime":"0","endTime":"0","summary":"Exicure (XCUR) announced that it will present a poster at the upcoming 2026 Tandem Meetings Transplantation & Cellular Therapy Meetings of the Amer...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/exicure-to-present-data-from-burixafor-phase-2-trial-at-2026-tandem-meetings-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/exicure-to-present-data-from-burixafor-phase-2-trial-at-2026-tandem-meetings-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2605562101","title":"Exicure Reports Positive Phase 2 Results for Burixafor in Multiple Myeloma Stem Cell Mobilization","url":"https://stock-news.laohu8.com/highlight/detail?id=2605562101","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605562101?lang=en_us&edition=fundamental","pubTime":"2026-01-21 20:00","pubTimestamp":1768996826,"startTime":"0","endTime":"0","summary":"Exicure Inc. announced that it will present data from its open-label, multicenter Phase 2 trial evaluating burixafor in patients with multiple myeloma undergoing autologous hematopoietic cell transplantation at the 2026 Tandem Meetings, taking place February 4-7, 2026, in Salt Lake City, UT. The poster presentation will feature previously reported results, highlighting that 89.7% of patients met the primary endpoint for successful stem cell mobilization using a regimen of burixafor, propranolol, and G-CSF. The data indicate that the combination provided reliable mobilization and a favorable safety profile. The presentation is scheduled for February 5, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the origi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nNDLbNcWGJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","XCUR","BK4112","LU2095319765.USD","SG9999014005.SGD","IE00B64PRP62.GBP","SG9999014039.USD","SG9999014021.USD","LU0314104364.USD","BK4139","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4588","BK4585"],"gpt_icon":0},{"id":"2605608145","title":"Exicure HiTron Inc. Reports Disposal of Exicure Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605608145","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605608145?lang=en_us&edition=fundamental","pubTime":"2026-01-21 03:09","pubTimestamp":1768936192,"startTime":"0","endTime":"0","summary":"Exicure HiTron Inc., a beneficial owner of Exicure Inc., has reported a disposal of common shares of Exicure Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL1H22lN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Exicure HiTron Inc. Reports Disposal of Exicure Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2602032317","title":"Exicure HiTron Inc. Reports Disposal of Exicure Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602032317","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602032317?lang=en_us&edition=fundamental","pubTime":"2026-01-09 09:43","pubTimestamp":1767922999,"startTime":"0","endTime":"0","summary":"Exicure HiTron Inc., a significant beneficial owner of Exicure Inc. , has reported the disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL8jK7f1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Exicure HiTron Inc. Reports Disposal of Exicure Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2590323126","title":"Crude Oil Down 1%; AutoZone Shares Dip After Q1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2590323126","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590323126?lang=en_us&edition=fundamental","pubTime":"2025-12-10 01:11","pubTimestamp":1765300316,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/25/12/49285954/crude-oil-down-1-autozone-shares-dip-after-q1-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4214","LU1934455194.USD","LU1196500208.SGD","LU0345770993.USD","LU0965509101.SGD","BK4588","LU1934455863.HKD","SLM","LU2517655028.SGD","BK4160","LU1506573853.SGD","LU1037948897.HKD","LU1221951046.USD","LU0345770308.USD","LU0965508806.USD","LU2463526074.USD","LU1934455277.USD","BK4167","LU0314106906.USD","LU0965509010.AUD","LU1037948541.HKD","BK4585","LU1221951129.SGD","LU0965509283.SGD","ALEX","TROX","LU2517655291.USD","SLMDA","AZO","BK4166","LU0234570918.USD","BK4563","LU0861579265.USD","XCUR","BK4212","LU1571399168.USD","LU2517655374.HKD","LU0053666078.USD","LU1032955483.USD","PHR","BK4139","BK4090"],"gpt_icon":1},{"id":"2590323374","title":"Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2590323374","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590323374?lang=en_us&edition=fundamental","pubTime":"2025-12-10 00:39","pubTimestamp":1765298340,"startTime":"0","endTime":"0","summary":"Exicure shares trade higher after Phase 2 data show nearly 90% of patients reached key cell collection targets using its burixafor combination in multiple myeloma.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/09/Molecule-Of-Dna-Forming-Inside-The-Test-.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/09/Molecule-Of-Dna-Forming-Inside-The-Test-.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/health-care/25/12/49284762/exicure-rally-fueled-by-rapid-cell-boosting-results-in-blood-cancer-trial","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49284762/exicure-rally-fueled-by-rapid-cell-boosting-results-in-blood-cancer-trial","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["JNJ","LU1506573853.SGD","LU2129689605.HKD","IE0002270589.USD","LU1061106388.HKD","IE00B19Z3581.USD","XCUR","BK4581","LU0345770308.USD","IE00BSNM7G36.USD","SG9999002232.USD","IE00B3T34201.USD","LU2750360641.GBP","LU0098860793.USD","LU1057294990.SGD","LU2089984988.USD","LU1585245621.USD","LU2129689514.USD","IE0002141913.USD","LU1430594728.SGD","LU1894683264.USD","LU0203345920.USD","IE00BJJMRZ35.SGD","LU1244550494.USD","LU1059921491.USD","IE00BFTCPJ56.SGD","LU1935042991.SGD","LU0432979614.USD","SG9999002224.SGD","LU2468319806.SGD","LU1066051225.USD","IE00B2B36J28.USD","IE00BKVL7J92.USD","LU0889566641.SGD","IE0034235303.USD","LU1674673691.USD","BK4588","IE0009355771.USD","LU1280957306.USD","IE00B4R5TH58.HKD","BK4007","LU1196500208.SGD","LU0234572021.USD","LU1267930813.SGD","IE00BLSP4239.USD","IE00B1BXHZ80.USD","SG9999001440.SGD","LU0345770993.USD","LU1894683348.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2590613364","title":"Stocks to Watch: Alexander & Baldwin, Exicure, Mama's Creations","url":"https://stock-news.laohu8.com/highlight/detail?id=2590613364","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590613364?lang=en_us&edition=fundamental","pubTime":"2025-12-09 07:37","pubTimestamp":1765237020,"startTime":"0","endTime":"0","summary":"Alexander & Baldwin is being taken private in a $1.54 billion deal. Shares jumped 37% to $20.70 in after-hours trading Monday.Exicure shared positive results from a Phase 2 trial of its blood cancer treatment. The stock climbed 83% to $9.85 after the bell.Mama's Creations recorded a 50% bump in revenue. Shares rose 18% to $13.16.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139","BK4160","ALEX","BK4212","MAMA"],"gpt_icon":0},{"id":"2590136159","title":"Exicure Surges on Positive Data for Blood Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2590136159","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590136159?lang=en_us&edition=fundamental","pubTime":"2025-12-09 06:43","pubTimestamp":1765233780,"startTime":"0","endTime":"0","summary":"Exicure stock surged after the biopharmaceutical company announced positive results from a Phase 2 trial of its blood cancer treatment.The stock more than doubled in after-hours trading Monday to $11.91, after closing at $5.33.The company said 90% of patients with multiple myeloma who were undergoing stem cell treatment and received doses of burixafor, in combination with certain other treatments, achieved the primary endpoint of the study.The treatment was effective even for participants who had previously received daratumumab, a therapy associated with reduced stem cell mobilization, Exicure said.The company added that the burixafor course of treatment demonstrated a good safety profile.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Exicure Surges on Positive Data for Blood Cancer Treatment","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2590036636","title":"Exicure Reports Positive Phase 2 Results for Burixafor in Multiple Myeloma Stem Cell Mobilization","url":"https://stock-news.laohu8.com/highlight/detail?id=2590036636","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590036636?lang=en_us&edition=fundamental","pubTime":"2025-12-09 05:30","pubTimestamp":1765229422,"startTime":"0","endTime":"0","summary":"Exicure Inc. announced positive topline results from a completed Phase 2 clinical trial evaluating burixafor  in combination with propranolol and granulocyte colony-stimulating factor  for mobilizing hematopoietic progenitor cells  in patients with multiple myeloma undergoing autologous hematopoietic cell transplantation. The data, presented at the 2025 American Society of Hematology  Annual Meeting, showed that approximately 90% of participants achieved the primary endpoint of collecting ≥2 × 10 CD34+ cells/kg within two leukapheresis sessions. The study reported a favorable safety profile and rapid mobilization kinetics, with peak peripheral CD34+ cell levels observed within one hour of burixafor administration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251208:nNDL4MvDBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","XCUR","BK4588","SG9999014039.USD","BK4112","NDAQ","SG9999014005.SGD","IE00B64PRP62.GBP","BK4139","IE00BKPKM429.USD","SG9999014013.SGD","SG9999014021.USD","LU2210149790.SGD"],"gpt_icon":0},{"id":"2584726546","title":"Exicure Inc. Announces Early Redemption of $3.1 Million Convertible Bonds to Simplify Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2584726546","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584726546?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:53","pubTimestamp":1763416403,"startTime":"0","endTime":"0","summary":"Exicure Inc. has announced the early redemption of 4.5 billion KRW  in 2.90% Convertible Bonds originally due in 2028. The bonds, issued by its subsidiary KC Creation Co., Ltd. and held internally by Exicure, were redeemed in full on November 10, 2025. This move is part of Exicure's ongoing efforts to streamline its intercompany financing and secure liquidity for its biotechnology operations. The transaction, funded through internal cash transfers and involving no third-party holders, is not expected to have a material impact on the company's consolidated financial statements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gather","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL7lDcfG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2582388654","title":"Exicure Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2582388654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582388654?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:18","pubTimestamp":1762809483,"startTime":"0","endTime":"0","summary":"Exicure Inc. held its 2025 Annual Meeting of Stockholders on November 6, 2025. During the meeting, stockholders elected two individuals to the board of directors and ratified the selection of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2025. All proposals presented at the meeting were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL1vC6ZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2581831358","title":"Biotechnology company Exicure Q3 net loss widens, existing cash not sufficient to continue to fund operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831358","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581831358?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:11","pubTimestamp":1762549868,"startTime":"0","endTime":"0","summary":"Biotechnology company Exicure Q3 net loss widens, existing cash not sufficient to continue to fund operationsOverviewExicure reports Q3 net loss of $2.4 mln, up from $1.1 mln last yearCompany's cash p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL1N3WJ166:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2581397898","title":"Exicure Q3 EPS $(0.39) Up From $(0.57) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2581397898","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581397898?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:01","pubTimestamp":1762549318,"startTime":"0","endTime":"0","summary":"Exicure Q3 EPS $(0.39) Up From $(0.57) YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48734306/exicure-q3-eps-0-39-up-from-0-57-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Exicure Q3 EPS $(0.39) Up From $(0.57) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2581839297","title":"Exicure reports third quarter net loss of $2.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581839297","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581839297?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:00","pubTimestamp":1762549224,"startTime":"0","endTime":"0","summary":"Exicure Inc. reported a cash and cash equivalents balance of $4.4 million as of September 30, 2025, compared to $12.5 million at the end of 2024. The company recorded a net loss of $2.4 million for the third quarter of 2025, up from a net loss of $1.1 million in the same period last year. Research and development expenses increased to $0.9 million for the quarter, compared to $0 in the previous year, primarily due to the acquisition of GPCR Therapeutics USA Inc. Exicure management stated that existing cash resources are insufficient to fund ongoing operations and that additional financing is needed in the short term.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exicure Inc. published the original content used to generate this news br","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL5fhvzQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0314104364.USD","BK4588","BK4112","IE00B3QW5Z07.USD","LU2210149790.SGD","NDAQ","BK4139","LU2210150020.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","XCUR","LU2095319765.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2581839221","title":"Exicure Q3 Operating Income USD -2.391 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581839221","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581839221?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:00","pubTimestamp":1762549201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nPLXB5CA6C:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XCUR","BK4139"],"gpt_icon":0},{"id":"2581392078","title":"Exicure Inc - Cash Not Sufficient to Fund Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2581392078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581392078?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:00","pubTimestamp":1762549201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nPLXB5CA6C:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","XCUR"],"gpt_icon":0},{"id":"2581831156","title":"Exicure, Inc. Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2581831156","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581831156?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:00","pubTimestamp":1762549200,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., Nov.  07, 2025  (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR, the “Company”) releases the following financial results for the fiscal quarter ended September 30, 2025. Third Qu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/07/3183943/33289/en/Exicure-Inc-Reports-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","XCUR"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}